TR200000958T2 - Hiperglisemi tedavisinde tiazolidinedion kullanımı. - Google Patents

Hiperglisemi tedavisinde tiazolidinedion kullanımı.

Info

Publication number
TR200000958T2
TR200000958T2 TR2000/00958T TR200000958T TR200000958T2 TR 200000958 T2 TR200000958 T2 TR 200000958T2 TR 2000/00958 T TR2000/00958 T TR 2000/00958T TR 200000958 T TR200000958 T TR 200000958T TR 200000958 T2 TR200000958 T2 TR 200000958T2
Authority
TR
Turkey
Prior art keywords
hyperglycemia
thiazolidinedione
treatment
mammal
toxic
Prior art date
Application number
TR2000/00958T
Other languages
English (en)
Inventor
Edwin Buckingham Robin
Alistair Smith Stephan
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200000958T2 publication Critical patent/TR200000958T2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Plazma glükoz seviyelerinin yüksek normal <=126mg/dl, arasinda oldugu hiperglisemi tedavisi için, ihtiyaci olan memeliye etkili toksik olmayan ve farmasötik olarak kabul edilebilir miktarda bir ensülin sensitizörü uygulanmasini içeren bir yöntem.
TR2000/00958T 1997-10-13 1998-10-12 Hiperglisemi tedavisinde tiazolidinedion kullanımı. TR200000958T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment

Publications (1)

Publication Number Publication Date
TR200000958T2 true TR200000958T2 (tr) 2000-08-21

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00958T TR200000958T2 (tr) 1997-10-13 1998-10-12 Hiperglisemi tedavisinde tiazolidinedion kullanımı.

Country Status (24)

Country Link
EP (1) EP1023056A1 (tr)
JP (1) JP2001519382A (tr)
KR (1) KR20010024481A (tr)
CN (1) CN1281359A (tr)
AP (1) AP2000001787A0 (tr)
AU (1) AU9547098A (tr)
BG (1) BG104404A (tr)
BR (1) BR9815219A (tr)
CA (1) CA2306086A1 (tr)
CZ (1) CZ20001297A3 (tr)
EA (1) EA002659B1 (tr)
GB (1) GB9721693D0 (tr)
HR (1) HRP20000255A2 (tr)
HU (1) HUP0003922A3 (tr)
ID (1) ID24521A (tr)
IL (1) IL135513A0 (tr)
NO (1) NO20001898L (tr)
NZ (1) NZ503862A (tr)
OA (1) OA11683A (tr)
PL (1) PL339813A1 (tr)
SK (1) SK5312000A3 (tr)
TR (1) TR200000958T2 (tr)
WO (1) WO1999018943A1 (tr)
YU (1) YU28800A (tr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
EA002659B1 (ru) 2002-08-29
BG104404A (bg) 2000-12-29
ID24521A (id) 2000-07-20
HUP0003922A3 (en) 2001-12-28
NO20001898L (no) 2000-06-09
EP1023056A1 (en) 2000-08-02
PL339813A1 (en) 2001-01-02
AP2000001787A0 (en) 2000-06-30
HUP0003922A2 (hu) 2001-10-28
NO20001898D0 (no) 2000-04-12
WO1999018943A1 (en) 1999-04-22
AU9547098A (en) 1999-05-03
BR9815219A (pt) 2001-01-02
JP2001519382A (ja) 2001-10-23
KR20010024481A (ko) 2001-03-26
SK5312000A3 (en) 2000-09-12
GB9721693D0 (en) 1997-12-10
OA11683A (en) 2005-01-12
YU28800A (sh) 2003-02-28
HRP20000255A2 (en) 2001-02-28
CZ20001297A3 (cs) 2001-08-15
CA2306086A1 (en) 1999-04-22
EA200000419A1 (ru) 2000-10-30
NZ503862A (en) 2003-01-31
CN1281359A (zh) 2001-01-24
IL135513A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
TR200100079T2 (tr) Glikoza karşı ß-hücre tepkisini arttıran glukagon benzeri peptid-1
SG127714A1 (en) Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes
EA200101089A1 (ru) Новый способ лечения
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
MXPA03003870A (es) Terapia de combinacion que comprende agentes antidiabeticos y anticonvulsionantes.
TR199902033T2 (tr) Diyabet için sülfonilura-glitazon sinerjik kombinasyonlari.
TR199903057T2 (tr) Diabetin tiazolidinedion ve metformin ile tedavisi.
CY1105254T1 (el) Θepαπεια του διαβητη με θειαζολιδινδιονη, εκκριταγωγο ινσουλινης και διγουανιδιο
TR200101174T2 (tr) Migren tedavisi için 5HT1, reseptör agonistleri ve metoklopramid.
IL143569A0 (en) A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes
BR0311161A (pt) Método de tratamento de diabetes
ES2193233T3 (es) Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.
NO20083276L (no) Behandling av diabetes med tiazolidindion og sulfonylurea
CY1107745T1 (el) Αγωγη του διαβητη με θειαζολιδινοδιονη και σουλφονυλουρια
TR199903095T2 (tr) Diabetin roziglitazon ve insülin ile tedavisi.
TR200000958T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı.
TR200101336T2 (tr) Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar
NO996270L (no) Behandling av diabetes med tiazolidindion og &lt;alfa&gt;- glukosidaseinhibitor
AR019724A2 (es) Composicion farmaceutica util para el tratamiento de diabetes mellitus y condiciones asociadas
TR200000957T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı
NO20003813L (no) FremgangsmÕter for Õ redusere eller forhindre smerte ved bruk av spicamycin eller derivater derav
TR200202033T2 (tr) Epilepsi Tedavisi İçin Terkipler ve Yöntemler
AU4193800A (en) Use of tagatose to enhance key blood factors
WO2001047509A3 (en) Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
TR199801133T2 (tr) Tip II diyabetin tedavisi veya önlenmesi için nitrik oksit (NO) sentaz inhibitörü